Trial Profile
Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2019
Price :
$35
*
At a glance
- Drugs Amlodipine/indapamide/perindopril (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms CONTROL-3
- Sponsors Servier
- 12 Feb 2019 Patient-reported adherence Results published in the Clinical Drug Investigation.
- 23 Mar 2017 Status changed from recruiting to completed.
- 28 Jan 2016 New trial record